An Open-label Pilot Study With an Extension Phase to Evaluate the Pharmacokinetics, and to Generate Preliminary Safety, Tolerability, and Efficacy of Perampanel (E2007) Oral Suspension When Given as an Adjunctive Therapy in Pediatric Subjects From 2 to Le

Grants and Contracts Details

StatusFinished
Effective start/end date10/3/12 → 9/30/15

Funding

  • Eisai Incorporated: $33,827.00